Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial
Publication
, Conference
Sandhu, RK; Ezekowitz, J; Hijazi, Z; Westerbergh, J; Alexander, JH; Granger, CB; Halvorsen, S; Hanna, MS; Lopes, RD; Wallentin, L
Published in: CIRCULATION
2017
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2017
Volume
136
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sandhu, R. K., Ezekowitz, J., Hijazi, Z., Westerbergh, J., Alexander, J. H., Granger, C. B., … Wallentin, L. (2017). Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial. In CIRCULATION (Vol. 136).
Sandhu, Roopinder K., Justin Ezekowitz, Ziad Hijazi, Johan Westerbergh, John H. Alexander, Christopher B. Granger, Sigrun Halvorsen, Michael S. Hanna, Renato D. Lopes, and Lars Wallentin. “Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial.” In CIRCULATION, Vol. 136, 2017.
Sandhu RK, Ezekowitz J, Hijazi Z, Westerbergh J, Alexander JH, Granger CB, et al. Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial. In: CIRCULATION. 2017.
Sandhu, Roopinder K., et al. “Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial.” CIRCULATION, vol. 136, 2017.
Sandhu RK, Ezekowitz J, Hijazi Z, Westerbergh J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Wallentin L. Obesity Paradox on Outcome in Atrial Fibrillation Maintained Even Considering the Prognostic Influence of Biomarkers: Insights From the ARISTOTLE Trial. CIRCULATION. 2017.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2017
Volume
136
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology